Overall, 55% of cases stained positively for HNF1B by IHC, and 37% of patients experienced one or more clinically-significant venous thromboembolic event, i.e. deep venous thrombosis (DVT), pulmonary embolism (PE), or stroke. Here, HNF1B is linked to pulmonary embolism.